Publications

2026

  1. 2026
  2. 2026
    The molecular heterogeneity and clinical impact of genomic driver alterations in prostate cancer.
    Pellegrina D, Kiriy D, C L Cheng K … Lutsik P … Reimand J
    Nat Commun
  3. 2026
    Integrated signatures define mutational processes in prostate cancer.
    Gruber AJ, Olsen AV, Hernando B … Lutsik P … Weischenfeldt J
    Nature
  4. 2026
  5. 2026
    GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.
    Müller J, Sofyali E, Schwarzmüller L … Lutsik P … Wiemann S
    Clin Epigenetics
  6. 2026

2025

  1. 2025
  2. 2025
  3. 2025
    Epigenetic clues from cancer's past foretell its future.
    Lutsik P, Manojlovic V, Vassiliou GS
    NatureCommentary
  4. 2025
    DNA demethylation-mediated downregulation of MNX1 in acute myeloid leukemia.
    Kelekçi S, Kelly K, Goyal A … Lutsik P … Plass C
    Leukemia
  5. 2025
    Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q.
    Sollier E, Riedel A, Toprak UH … Lutsik P … Plass C
    Blood Cancer DiscovPyjacker
  6. 2025
    Causes of evolutionary divergence in prostate cancer.
    Esentürk E, Sahli A, Haberland V … Lutsik P … Woodcock DJ
    ArXivPreprint
  7. 2025
    MethylBERT enables read-level DNA methylation pattern identification and tumour deconvolution using a Transformer-based model.
    Jeong Y, Gerhäuser C, Sauter G, Schlomm T, Rohr K, Lutsik P
    Nat CommunMethylBERT

2024

  1. 2024
    EpiCHAOS: a metric to quantify epigenomic heterogeneity in single-cell data.
    Kelly K, Scherer M, Braun MM, Lutsik P, Plass C
    Genome BiolepiCHAOS
  2. 2024
    SRSF2 safeguards efficient transcription of DNA damage and repair genes.
    Wagner RE, Arnetzl L, Britto-Borges T … Lutsik P … Frye M
    Cell Rep
  3. 2024
  4. 2024
    Dnmt3a1 regulates hippocampus-dependent memory via the downstream target Nrp1.
    Kupke J, Klimmt J, Mudlaff F … Lutsik P … Oliveira AMM
    Neuropsychopharmacology
  5. 2024
  6. 2024
  7. 2024
    Figeno: multi-region genomic figures with long-read support.
    Sollier E, Heilmann J, Gerhauser C, Scherer M, Plass C, Lutsik P
    Bioinformaticsfigeno
  8. 2024
  9. 2024

2023

  1. 2023
  2. 2023
    Heterogeneity in the gene regulatory landscape of leiomyosarcoma.
    Belova T, Biondi N, Hsieh PH, Lutsik P, Chudasama P, Kuijjer ML
    NAR Cancer
  3. 2023
    Translocation t(6;7) in AML-M4 cell line GDM-1 results in MNX1 activation through enhancer-hijacking.
    Weichenhan D, Riedel A, Meinen C … Lutsik P … Plass C
    Leukemia
  4. 2023
    TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer.
    Smith C, Goyal A, Weichenhan D … Lutsik P … Touzart A
    Haematologica
  5. 2023
    The GAPDH redox switch safeguards reductive capacity and enables survival of stressed tumour cells.
    Talwar D, Miller CG, Grossmann J … Lutsik P … Dick TP
    Nat Metab
  6. 2023
    Dynamic DNA methylation reveals novel cis-regulatory elements in mouse hematopoiesis.
    Schönung M, Hartmann M, Krämer S … Lutsik P … Lipka DB
    Exp Hematol

2022

  1. 2022
  2. 2022
    Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors.
    Zaremba A, Jansen P, Murali R … Lutsik P … Griewank K
    Int J Cancer
  3. 2022
    Epigenomic technologies for precision oncology.
    Weichenhan D, Lipka DB, Lutsik P, Goyal A, Plass C
    Semin Cancer BiolReview
  4. 2022
    Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions.
    Zaremba A, Jansen P, Murali R … Lutsik P … Griewank K
    Cancers (Basel)
  5. 2022
    Club cells employ regeneration mechanisms during lung tumorigenesis.
    Chen Y, Toth R, Chocarro S … Lutsik P … Sotillo R
    Nat Commun
  6. 2022
    Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancer.
    Revia S, Seretny A, Wendler L … Lutsik P … Tschaharganeh DF
    Gut
  7. 2022
    Systematic evaluation of cell-type deconvolution pipelines for sequencing-based bulk DNA methylomes.
    Jeong Y, de Andrade E Sousa LB, Thalmeier D … Lutsik P
    Brief Bioinform
  8. 2022

2021

  1. 2021
  2. 2021
  3. 2021
    AmpliconDesign - an interactive web server for the design of high-throughput targeted DNA methylation assays.
    Schönung M, Hess J, Bawidamann P … Lutsik P … Lipka DB
    EpigeneticsAmpliconDesign
  4. 2021
  5. 2021
    Activation-induced deaminase is critical for the establishment of DNA methylation patterns prior to the germinal center reaction.
    Català-Moll F, Ferreté-Bonastre AG, Li T … Lutsik P … Ballestar E
    Nucleic Acids Res
  6. 2021
  7. 2021
    Methrix: an R/Bioconductor package for systematic aggregation and analysis of bisulfite sequencing data.
    Mayakonda A, Schönung M, Hey J … Lutsik P … Toth R
    Bioinformaticsmethrix
  8. 2021
    Versatile workflow for cell type-resolved transcriptional and epigenetic profiles from cryopreserved human lung.
    Llamazares-Prada M, Espinet E, Mijošek V … Lutsik P … Jurkowska RZ
    JCI Insight
  9. 2021
    Bisulfite-free epigenomics and genomics of single cells through methylation-sensitive restriction.
    Niemöller C, Wehrle J, Riba J … Lutsik P … Becker H
    Commun Biol

2020

  1. 2020
  2. 2020
  3. 2020
  4. 2020
    Neuronal ensemble-specific DNA methylation strengthens engram stability.
    Gulmez Karaca K, Kupke J, Brito DVC … Lutsik P … Oliveira AMM
    Nat Commun
  5. 2020

2019

  1. 2019
  2. 2019
    Integrative Analysis Defines Distinct Prognostic Subgroups of Intrahepatic Cholangiocarcinoma.
    Goeppert B, Toth R, Singer S … Lutsik P … Roessler S
    Hepatology
  3. 2019
    RnBeads 2.0: comprehensive analysis of DNA methylation data.
    Müller F, Scherer M, Assenov Y … Lutsik P … Bock C
    Genome BiolRnBeads
  4. 2019

2018

  1. 2018
    Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.
    Gerhauser C, Favero F, Risch T … Lutsik P … Weischenfeldt J
    Cancer Cell
  2. 2018
    From Basic Knowledge to Effective Therapies.
    Lipka DB, Lutsik P, Plass C
    Cancer CellCommentary
  3. 2018

2017

  1. 2017
    MeDeCom: discovery and quantification of latent components of heterogeneous methylomes.
    Lutsik P, Slawski M, Gasparoni G, Vedeneev N, Hein M, Walter J
    Genome BiolMeDeCom

2016

  1. 2016

2015

  1. 2015
    Epigenome data release: a participant-centered approach to privacy protection.
    Dyke SO, Cheung WA, Joly Y … Lutsik P … Pastinen T
    Genome Biol

2014

  1. 2014
    AKSmooth: enhancing low-coverage bisulfite sequencing data via kernel-based smoothing.
    Chen J, Lutsik P, Akulenko R, Walter J, Helms V
    J Bioinform Comput Biol
  2. 2014
    Comprehensive analysis of DNA methylation data with RnBeads.
    Assenov Y, Müller F, Lutsik P, Walter J, Lengauer T, Bock C
    Nat MethodsRnBeads
  3. 2014
    BiQ Analyzer HiMod: an interactive software tool for high-throughput locus-specific analysis of 5-methylcytosine and its oxidized derivatives.
    Becker D, Lutsik P, Ebert P, Bock C, Lengauer T, Walter J
    Nucleic Acids ResBiQ Analyzer HiMod

2013

  1. 2013
    Bi-PROF: bisulfite profiling of target regions using 454 GS FLX Titanium technology.
    Gries J, Schumacher D, Arand J … Lutsik P … Tierling S
    Epigenetics
  2. 2013

2011

  1. 2011
    BiQ Analyzer HT: locus-specific analysis of DNA methylation by high-throughput bisulfite sequencing.
    Lutsik P, Feuerbach L, Arand J, Lengauer T, Walter J, Bock C
    Nucleic Acids ResBiQ Analyzer HT

2010

  1. 2010
    Assisted reproductive technologies do not enhance the variability of DNA methylation imprints in human.
    Tierling S, Souren NY, Gries J … Lutsik P … Walter J
    J Med Genet